Literature DB >> 2854351

Japanese encephalitis vaccine.

A Oya.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2854351     DOI： 10.1111/j.1442-200x.1988.tb02516.x

Source DB:  PubMed          Journal:  Acta Paediatr Jpn        ISSN： 0374-5600


× No keyword cloud information.
  20 in total

1.  Japanese encephalitis vaccine in travellers. Is wider use prudent?

Authors:  T Jelinek; H D Nothdurft
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

2.  Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children.

Authors:  Emmanuel Feroldi; Maria Rosario Capeding; Mark Boaz; Sophia Gailhardou; Claude Meric; Alain Bouckenooghe
Journal:  Hum Vaccin Immunother       Date:  2013-02-26       Impact factor: 3.452

3.  Phase III clinical trials comparing the immunogenicity and safety of the vero cell-derived Japanese encephalitis vaccine Encevac with those of mouse brain-derived vaccine by using the Beijing-1 strain.

Authors:  Chiaki Miyazaki; Kenji Okada; Takao Ozaki; Mizuo Hirose; Kaneshige Iribe; Hiroyuki Yokote; Yuji Ishikawa; Takehiro Togashi; Kohji Ueda
Journal:  Clin Vaccine Immunol       Date:  2013-12-11

4.  The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes.

Authors:  E Konishi; M Yamaoka; I Kurane; K Takada; P W Mason
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

5.  Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity.

Authors:  Peter E Nasveld; Joanne Marjason; Sonya Bennett; John Aaskov; Suzanne Elliott; Karen McCarthy; Niranjan Kanesa-Thasan; Emmanuel Feroldi; Mark Reid
Journal:  Hum Vaccin       Date:  2010-11-01

6.  Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus.

Authors:  A Yasuda; J Kimura-Kuroda; M Ogimoto; M Miyamoto; T Sata; T Sato; C Takamura; T Kurata; A Kojima; K Yasui
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

7.  DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice.

Authors:  Y L Lin; L K Chen; C L Liao; C T Yeh; S H Ma; J L Chen; Y L Huang; S S Chen; H Y Chiang
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

8.  JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody.

Authors:  Maximilian Larena; Natalie A Prow; Roy A Hall; Nikolai Petrovsky; Mario Lobigs
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

Review 9.  Japanese encephalitis and vaccines: past and future prospects.

Authors:  Maria Paulke-Korinek; Herwig Kollaritsch
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

10.  Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance.

Authors:  Susan Hills; Alya Dabbagh; Julie Jacobson; Anthony Marfin; David Featherstone; Joachim Hombach; Pem Namgyal; Manju Rani; Tom Solomon
Journal:  BMC Infect Dis       Date:  2009-12-29       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.